Cargando…
Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study
INTRODUCTION: Lung cancer is the leading cause of cancer death in the USA and worldwide, and lung cancer screening (LCS) with low-dose CT (LDCT) has the potential to improve lung cancer outcomes. A critical question is whether the ratio of potential benefits to harms found in prior LCS trials applie...
Autores principales: | Braithwaite, Dejana, Karanth, Shama D, Slatore, Christopher G, Zhang, Dongyu, Bian, Jiang, Meza, Rafael, Jeon, Jihyoun, Tammemagi, Martin, Schabath, Mattthew, Wheeler, Meghann, Guo, Yi, Hochhegger, Bruno, Kaye, Frederic J, Silvestri, Gerard A, Gould, Michael K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226937/ https://www.ncbi.nlm.nih.gov/pubmed/35732383 http://dx.doi.org/10.1136/bmjopen-2022-064142 |
Ejemplares similares
-
Survival Differences by Comorbidity Burden among Patients with Stage I/II Non-Small-Cell Lung Cancer after Thoracoscopic Resection
por: Wheeler, Meghann, et al.
Publicado: (2023) -
Inflammation in Relation to Sarcopenia and Sarcopenic Obesity among Older Adults Living with Chronic Comorbidities: Results from the National Health and Nutrition Examination Survey 1999–2006
por: Karanth, Shama D., et al.
Publicado: (2021) -
Associations of Total Body Fat Mass and Skeletal Muscle Index with All-Cause and Cancer-Specific Mortality in Cancer Survivors
por: Aduse-Poku, Livingstone, et al.
Publicado: (2023) -
PluS Nanoparticles Loaded with Sorafenib: Synthetic
Approach and Their Effects on Endothelial Cells
por: Palomba, Francesco, et al.
Publicado: (2019) -
PLU1 Promotes the Proliferation and Migration of Glioma Cells and Regulates Metabolism
por: Dong, Wentao, et al.
Publicado: (2023)